Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 18;9(9):CD006110.
doi: 10.1002/14651858.CD006110.pub5.

Antibiotics for treating acute chest syndrome in people with sickle cell disease

Arturo J Martí-Carvajal  1 , Lucieni O Conterno, Jennifer M Knight-Madden
Affiliations

Antibiotics for treating acute chest syndrome in people with sickle cell disease

Arturo J Martí-Carvajal et al. Cochrane Database Syst Rev. .

Abstract

Background: The clinical presentation of acute chest syndrome is similar whether due to infectious or non-infectious causes, thus antibiotics are usually prescribed to treat all episodes. Many different pathogens, including bacteria, have been implicated as causative agents of acute chest syndrome. There is no standardized approach to antibiotic therapy and treatment is likely to vary from country to country. Thus, there is a need to identify the efficacy and safety of different antibiotic treatment approaches for people with sickle cell disease suffering from acute chest syndrome. This is an update of a Cochrane Review first published in 2007, and most recently updated in 2015.

Objectives: To determine whether an empirical antibiotic treatment approach (used alone or in combination):1. is effective for acute chest syndrome compared to placebo or standard treatment;2. is safe for acute chest syndrome compared to placebo or standard treatment;Further objectives are to determine whether there are important variations in efficacy and safety:3. for different treatment regimens,4. by participant age, or geographical location of the clinical trials.

Search methods: We searched The Group's Haemoglobinopathies Trials Register, which comprises references identified from comprehensive electronic database searches and handsearching of relevant journals and abstract books of conference proceedings. We also searched the LILACS database (1982 to 23 October 2017), African Index Medicus (1982 to 23 October 2017) and trial registries (23 October 2017).Date of most recent search of the Haemoglobinopathies Trials Register: 10 July 2019.

Selection criteria: We searched for published or unpublished randomised controlled trials.

Data collection and analysis: Each author intended to independently extract data and assess trial quality by standard Cochrane methodologies, but no eligible randomised controlled trials were identified.

Main results: For this update, we were unable to find any randomised controlled trials on antibiotic treatment approaches for acute chest syndrome in people with sickle cell disease.

Authors' conclusions: This update was unable to identify randomised controlled trials on efficacy and safety of the antibiotic treatment approaches for people with sickle cell disease suffering from acute chest syndrome. While randomised controlled trials are needed to establish the optimum antibiotic treatment for this condition, we do not envisage further trials of this intervention will be conducted, and hence the review will no longer be regularly updated.

PubMed Disclaimer

Conflict of interest statement

In 2004 Arturo Martí‐Carvajal was employed by Eli Lilly to run a four‐hour workshop on 'How to critically appraise clinical trials on osteoporosis and how to teach this'. This activity was not related to his work with the Cochrane Collaboration or any Cochrane Review.

In 2007 Arturo Martí‐Carvajal was employed by Merck to run a four‐hour workshop 'How to critically appraise clinical trials and how to teach this'. This activity was not related to his work with the Cochrane Collaboration or any Cochrane Review.

Update of

References

Additional references

Al 2008
    1. Al Hajeri A, Serjeant GR, Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No: CD006957. [DOI: 10.1002/14651858.CD006957] - DOI - PMC - PubMed
Alabdulaali 2007
    1. Alabdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Annals of Thoracic Medicine 2007;2(4):158-62. - PMC - PubMed
Alayash 2017
    1. Alayash AI. Oxidative pathways in the sickle cell and beyond. Blood cells, Molecules and Diseases 2017;May 20:Epub ahead of print. [PMID: ] - PMC - PubMed
Alderson 2000
    1. Alderson P, Roberts I. Should journals publish systematic reviews that find no evidence to guide practice? Examples from injury research. BMJ 2000;320(7231):376-7. - PMC - PubMed
Balshem 2011
    1. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [PMID: ] - PubMed
Barrett‐Connor 1971a
    1. Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. The American Review of Respiratory Disease 1971;104(2):159-65. - PubMed
Barrett‐Connor 1971b
    1. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971;50(2):97-112. - PubMed
Basch 2012
    1. Basch E, Aronson N, Berg A, Flum D, Gabriel S, Goodman SN, et al. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA 2012;307(15):1636-40. - PubMed
Bennewitz 2017
    1. Bennewitz MF, Jimenez MA, Vats R, Tutuncuoglu E, Jonassaint J, Kato GJ, et al. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli. JCI Insight 2017;2(1):e89761. [PMID: ] - PMC - PubMed
Benza 2008
    1. Benza RL. Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment. Lung 2008;186(4):247-54. - PubMed
Bonds 2005
    1. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Review 2005;19(2):99-110. - PubMed
Boyd 2004
    1. Boyd JH, Moinuddin A, Strunk RC, DeBaun MR. Asthma and acute chest in sickle-cell disease. Pediatric Pulmonology 2004;38(3):229-32. - PubMed
Buchanan 2005
    1. Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatric Blood & Cancer 2005;45(5):716-24. - PubMed
Bundy 2017
    1. Bundy DG, Richardson TE, Hall M, Raphael JL, Brousseau DC, Arnold SD, et al. Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome. JAMA Pediatrics 2017;11:Epub ahead of print. [PMID: ] - PMC - PubMed
Chalmers 2004
    1. Chalmers I. Well informed uncertainties about the effects of treatments. How clinicians and patients respond? BMJ 2004;328(7438):475-6. - PMC - PubMed
Chan 2013a
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. - PMC - PubMed
Chan 2013b
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Annals of Internal Medicine 2013;158(3):200-7. - PMC - PubMed
Charache 1979
    1. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Archives of Internal Medicine 1979;139(1):67-9. - PubMed
Chaturvedi 2016
    1. Chaturvedi S, Ghafuri DL, Glassberg J, Kassim AA, Rodeghier M, DeBaun MR. Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype. American Journal of Hematology 2016;91(12):1185-90. [PMID: ] - PubMed
Dastgiri 2016
    1. Dastgiri S, Dolatkhah R. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No: CD007843. [DOI: 10.1002/14651858.CD007843.pub3] - DOI - PubMed
Davies 1984
    1. Davies SC, Luce PJ, Win AA, Riordan JF, Brozovic M. Acute chest syndrome in sickle-cell disease. Lancet 1984;323(8367):36-8. - PubMed
Dean 2003
    1. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, et al. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. Journal of Pediatric Hematology/Oncology 2003;25(1):46-55. - PubMed
Delatte 1999
    1. Delatte SJ, Hebra A, Tagge EP, Jackson S, Jacques K, Othersen HB Jr. Acute chest syndrome in the postoperative sickle cell patient. Journal of Pediatric Surgery 1999;34(1):188-91. - PubMed
Duckworth 2007
    1. Duckworth L, Hsu L, Feng H, Wang J, Sylvester JE, Kissoon N, et al. Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatric Pulmonology 2007;42(4):332-8. - PubMed
Fauroux 1999
    1. Fauroux B, Tamalet A, Desmarquest P, Clément A. Pathophysiology of acute thoracic syndrome. Pathologie-biologie 1999;47(1):26-30. - PubMed
Gabriel 2012
    1. Gabriel SE, Normand SL. Getting the Methods Right - The Foundation of Patient-Centered Outcomes Research. New England Journal of Medicine 2012;367(9):787-90. [PMID: ] - PubMed
Garrido 2017
    1. Garrido VT, Sonzogni L, Mtatiro SN, Costa FF, Conran N, Thein SL. Association of plasma CD40L with acute chest syndrome in sickle cell anemia. Cytokine 2017;97:104-7. [PMID: ] - PubMed
GRADEPro 2008 [Computer program]
    1. McMaster University GRADEpro. Brozek J, Oxman A, Schünemann H, Version 3.2 for Windows. McMaster University, 2008.
Guyatt 2011
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. - PubMed
Guyatt 2011a
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302. - PubMed
Guyatt 2011b
    1. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence--publication bias. Journal of Clinical Epidemiology 2011;64(12):1277-82. - PubMed
Guyatt 2011c
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. - PubMed
Guyatt 2011d
    1. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311-6. - PubMed
Guyatt 2011e
    1. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15. - PubMed
Guyatt 2011f
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94. - PubMed
Guyatt 2011g
    1. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2. - PubMed
Hierso 2017
    1. Hierso R, Lemonne N, Villaescusa R, Lalanne-Mistrih ML, Charlot K, Etienne-Julan M, et al. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study. British Journal of Haematology 2017;176(5):805-13. [PMID: ] - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Ioannidis 2004
    1. Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781-8. - PubMed
Jaiyesimi 2007
    1. Jaiyesimi O, Kasem M. Acute chest syndrome in Omani children with sickle cell disease: epidemiology and clinical profile. Annals of Tropical Paediatrics 2007;27(3):193-9. - PubMed
Johnson 2005
    1. Johnson CS. The acute chest syndrome. Hematology/Oncology Clinics of North America 2005;19(5):857-79. - PubMed
Kato 2009a
    1. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. American Journal of Hematology 2009;84(9):618-25. - PMC - PubMed
Kato 2009b
    1. Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG 6th, Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology 2009;145(4):506-13. - PMC - PubMed
Keenan 2017
    1. Keenan SE, Shvartsman SY. Mechanisms and causality in molecular diseases. History and Philosophy of the Life Sciences 2017;39(4):35. [PMID: ] - PMC - PubMed
Klings 2001
    1. Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respiratory Research 2001;2(5):280-5. - PMC - PubMed
Knight‐Madden 2005
    1. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60(3):206-10. - PMC - PubMed
Knight‐Madden 2016
    1. Knight-Madden JM, Hambleton IR. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No: CD003733. [DOI: 10.1002/14651858.CD003733.pub4] - DOI - PMC - PubMed
Kokoska 2004
    1. Kokoska ER, West KW, Carney DE, Engum SE, Heiny ME, Rescorla FJ. Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery. Journal of Pediatric Surgery 2004;39(6):848-50. - PubMed
Kopecky 2004
    1. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clinical Pharmacology and Therapeutics 2004;75(3):140-6. - PubMed
Lee 2005
    1. Lee WL, Slutsky AS. Hypoxemic Respiratory Failure, Including Acute Respiratory Distress Syndrome. In: Murray & Nadel's Textbook of Respiratory Medicine. Saunders, 2005.
Lonergan 2001
    1. Lonergan GJ, Cline DB, Abbondanzo SL. Sickle cell anemia. Radiographics 2001;21(4):971-94. - PubMed
Lottenberg 2005
    1. Lottenberg R, Hassell KL. An evidence-based approach to the treatment of adults with sickle cell disease. In: Hematology / The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2005:58-65. - PubMed
Lowenthal 1996
    1. Lowenthal EA, Wells A, Emanuel PD, Player R, Prchal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. American Journal of Hematology 1996;51(3):207-13. - PubMed
Mahdi 2009
    1. Mahdi N, Al-Subaie AM, Al-Ola K, Al-Irhayim AQ, Ali ME, Al-Irhayim Z, et al. HLA DRB1*130101-DQB1*060101 haplotype is associated with acute chest syndrome in sickle cell anemia patients. Tissue Antigens 2009;73(3):245-9. - PubMed
Mankad 2001
    1. Mankad VN. Exciting new treatment approaches for pathophysiologic mechanisms of sickle cell disease. Pediatric Pathology & Molecular Medicine 2001;20:1-13. - PubMed
Mekontso Dessap 2008
    1. Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine 2008;177(6):646-53. - PubMed
Moher 2010
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 2010;63(8):e1-37. [PMID: ] - PubMed
Morris 2008
    1. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. In: Hematology / the Education Program of the American Society of Hematology. Philadelphia: American Society of Hematology, 2008:177-85. - PubMed
Nebeker 2004
    1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Annals of Internal Medicine 2004;140(10):795-801. - PubMed
Neumayr 2003
    1. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics 2003;112(1 Pt 1):87-95. - PubMed
Nordness 2005
    1. Nordness ME, Lynn J, Zacharisen MC, Scott PJ, Kelly KJ. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clinical and molecular allergy: CMA [electronic resource] 2005;3:2. - PMC - PubMed
Novelli 2016
    1. Novelli EM, Gladwin MT. Crises in sickle cell disease. Chest 2016;149(4):1082-93. [PMID: ] - PMC - PubMed
Pauling 1949
    1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110:543-6. - PubMed
Piel 2016
    1. Piel FB. The present and future global burden of the inherited disorders of hemoglobin. Hematology/Oncology Clinics of North America 2016;30(2):327-41. [PMID: ] - PubMed
Piel 2017
    1. Piel FB, Steinberg MH, Rees DC. Sickle cell disease. New England Journal of Medicine 2017;376(16):1561-73. [PMID: ] - PubMed
Pincez 2016
    1. Pincez T, Calamy L, Germont Z, Lemoine A, Lopes AA, Massiot A, et al. [Pulmonary complications of sickle cell disease in children] [Atteintes pulmonaires au cours de la drepanocytose chez l'enfant]. Archives de Pediatrie 2016;23(10):1094-106. [PMID: ] - PubMed
Platt 1994
    1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine 1994;330(23):1639-44. - PubMed
Poncz 1985
    1. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. Journal of Pediatrics 1985;107(6):861-6. - PubMed
Quinn 1999
    1. Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. Journal of Pediatrics 1999;135(4):416-22. - PubMed
Salzman 2002
    1. Salzman SH. Does splinting from thoracic bone ischemia and infarction contribute to the acute chest syndrome in sickle cell disease? Chest 2002;122(1):6-9. - PubMed
Schimmel 2017
    1. Schimmel M, Luken BM, Nur E, Tuijn CFJ, Sins JW, Brandjes DPM, et al. Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease. American Journal of Hematology 2017;92(11):E634-6. [PMID: ] - PubMed
Serarslan 2009
    1. Serarslan G, Akgül F, Babayigit C. High prevalence of pulmonary hypertension in homozygous sickle cell patients with leg ulceration. Clinical and Experimental Hypertension 2009;31(1):44-8. - PubMed
Siddiqui 2003
    1. Siddiqui AK, Ahmed S. Pulmonary manifestations of sickle cell disease. Postgraduate Medical Journal 2003;79(933):384-90. - PMC - PubMed
Silvester 2007
    1. Sylvester KP, Patey RA, Broughton S, Rafferty GF, Rees D, Thein SL, et al. Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatric Pulmonology 2007;42(2):103-6. - PubMed
Strouse 2008
    1. Strouse JJ, Takemoto CM, Keefer JR, Kato GJ, Casella JF. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatric Blood & Cancer 2008;50(5):1006-12. - PMC - PubMed
Suara 2001
    1. Suara RO. Group A beta-haemolytic streptococcal acute chest event in a child with sickle cell anaemia. Annals of Tropical Paediatrics 2001;21(2):175-8. - PubMed
Subramaniam 2016
    1. Subramaniam S, Chao JH. Managing acute complications of sickle cell disease in pediatric patients. Pediatric Emergency Medicine Practice 2016;13(11):1-28. [PMID: ] - PubMed
Suell 2005
    1. Suell MN, Bezold LI, Okcu MF, Mahoney DH Jr, Shardonofsky F, Mueller BU. Increased pulmonary artery pressures among adolescents with sickle cell disease. Journal of Pediatric Hematology/Oncology 2005;27(12):654-58. - PubMed
Sullivan 2008
    1. Sullivan KJ, Kissoon N, Gauger C. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia. Pediatric Critical Care Medicine 2008;9(2):159-68. - PubMed
Sylvester 2006
    1. Sylvester KP, Patey RA, Milligan P, Rafferty GF, Broughton S, Rees D et al. Impact of acute chest syndrome on lung function of children with sickle cell disease. Journal of Pediatrics 2006;149(1):17-22. - PubMed
Taylor 2004
    1. Taylor C, Carter F, Poulose J, Rolle S, Babu S, Crichlow S. Clinical presentation of acute chest syndrome in sickle cell disease. Postgraduate Medical Journal 2004;80(944):346-9. - PMC - PubMed
Turner 2012
    1. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No: MR000030. [DOI: 10.1002/14651858.MR000030.pub2] - DOI - PMC - PubMed
van Agtmael 1994
    1. Agtmael MA, Cheng JD, Nossent HC. Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Analysis of 81 episodes among 53 patients. Archives of Internal Medicine 1994;154(5):557-61. - PubMed
van Tuijn 2017
    1. Tuijn CFJ, Schimmel M, Beers EJ, Nur E, Biemond BJ. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study. American Journal of Hematology 2017;92(10):E584-90. [PMID: ] - PubMed
Vichinsky 2000
    1. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal Medicine 2000;342(25):1855-65. - PubMed
Wales 2001
    1. Wales PW, Carver E, Crawford MW, Kim PC. Acute chest syndrome after abdominal surgery in children with sickle cell disease: Is a laparoscopic approach better? Journal of Pediatric Surgery 2001;36(5):718-21. - PubMed
Wang 2004
    1. Wang WC. Unstable Hemoglobin Disease. In: Greer JP, Foerster J, Lukens JN, Rogers GM, Frixos P, Glader BE, editors(s). Wintrobe's Clinical Hematology. 11th edition. Lippincott Williams & Wilkins, 2003.
Wang 2017
    1. Wang MX, Pepin EW, Verma N, Mohammed TL. Manifestations of sickle cell disease on thoracic imaging. Clinical Imaging 2017;48:Epub ahead of print. [PMID: ] - PubMed
Ware 2017
    1. Ware RE, Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet 2017;390(10091):311-23. [PMID: ] - PubMed
Wierenga 2001
    1. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001;357(9257):680-3. - PubMed
Wood 2008
    1. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology and Medicine 2008;44(8):1506-28. - PubMed
Young 1992
    1. Young RC Jr, Rachal RE, Hackney RL Jr, Uy CG, Scott RB. Smoking is a factor in causing acute chest syndrome in sickle cell anemia. Journal of the National Medical Association 1992;84(3):267-71. - PMC - PubMed
Zavala 2006 [Computer program]
    1. Sheet to enter data for performing a Cochrane review. Zavala D, Martí A, Peña-Martí G, Comunián G, Version 1. Valencia, Venezuela: Universidad de Carabobo, 2006. http://www.cochrane.fcs.uc.edu.ve/hrs/.

References to other published versions of this review

Martí‐Carvajal 2006
    1. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD006110. [DOI: 10.1002/14651858.CD006110] - DOI - PubMed
Martí‐Carvajal 2007
    1. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD006110. [DOI: 10.1002/14651858.CD006110.pub2] [MEDLINE: ] - DOI - PubMed
Martí‐Carvajal 2010
    1. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No: CD006110. [DOI: 10.1002/14651858.CD006110.pub2] - DOI - PubMed
Martí‐Carvajal 2013
    1. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No: CD006110. [DOI: 10.1002/14651858.CD006110.pub3] - DOI - PubMed
Martí‐Carvajal 2015
    1. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No: CD006110. [DOI: 10.1002/14651858.CD006110.pub4] - DOI - PMC - PubMed

Publication types

Substances